Protein turnover in mycobacterial proteomics

Molecules

Volumn 14, Issue 9, 2009, Pages 3237-3258

  Rao, Prahlad K ^a   Li, Qingbo ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Mycobacterium tuberculosis; Protein turnover; Proteome dynamics; Stress response

Indexed keywords

BACTERIAL PROTEIN; PROTEOME;

CYTOLOGY; METABOLISM; MYCOBACTERIUM; PROTEOMICS; REVIEW;

BACTERIAL PROTEINS; MYCOBACTERIUM; PROTEOME; PROTEOMICS;

EID: 70349514678     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14093237     Document Type: Review

References (90)

1. Martinez, L.; Blanc, L.; Nunn, P.; Raviglione, M. Tuberculosis and air travel: WHO guidance in the era of drug-resistant TB. Travel Med. Infect. Dis. 2008, 6, 177-181.
2. Hirsch-Moverman, Y.; Daftary, A.; Franks, J.; Colson, P.W. Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int. J. Tuberc. Lung Dis. 2008, 12, 1235-1254.
3. Wayne, L.G.; Sohaskey, C.D. Nonreplicating persistence of mycobacterium tuberculosis. Ann. Rev. Microbiol. 2001, 55, 139-163.
4. Nuermberger, E.; Bishai, W.R.; Grosset, J.H. Latent tuberculosis infection. Semin. Respir. Crit. Care Med. 2004, 25, 317-336.
5. Gomez, J.E.; McKinney, J.D. M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb) 2004, 84, 29-44.
6. WHO. Tuberculosis fact sheet Number 104. World Health OrganizationGeneva, Switzerland, 2004.
7. Koul, A.; Vranckx, L.; Dendouga, N.; Balemans, W.; Van den Wyngaert, I.; Vergauwen, K.; Gohlmann, H.W.; Willebrords, R.; Poncelet, A.; Guillemont, J.; Bald, D.; Andries, K. Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis. J. Biol. Chem. 2008, 283, 25273-25280.
8. Singh, R.; Manjunatha, U.; Boshoff, H.I.; Ha, Y.H.; Niyomrattanakit, P.; Ledwidge, R.; Dowd, C. S.; Lee, I.Y.; Kim, P.; Zhang, L.; Kang, S.; Keller, T.H.; Jiricek, J.; Barry, C.E. 3rd, PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release. Science 2008, 322, 1392-1395.
9. Hugonnet, J.E.; Tremblay, L.W.; Boshoff, H.I.; Barry, C.E. 3rd; Blanchard, J.S., Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis. Science 2009, 323, 1215-1218.
10. Walburger, A.; Koul, A.; Ferrari, G.; Nguyen, L.; Prescianotto-Baschong, C.; Huygen, K.; Klebl, B.; Thompson, C.; Bacher, G.; Pieters, J. Protein kinase G from pathogenic mycobacteria promotes survival within macrophages. Science 2004, 304, 1800-1804.
11. Gelband, H. Regimens of less than six months for treating tuberculosis. Cochrane Database Syst. Rev. 2000, CD001362.
12. Holland, D.P.; Sanders, G.D.; Hamilton, C.D.; Stout, J.E. Costs and Cost Effectiveness of Four Treatment Regimens for Latent Tuberculosis Infection. Am. J. Respir. Crit. Care Med. 2009, 179, 1055-1060.
13. Fox, W.; Ellard, G.A.; Mitchison, D.A., Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. Int. J. Tuberc. Lung Dis. 1999, 3, S231-S279.
14. Thadepalli, H.; Bach, V.T.; Webb, D.W. Antimicrobial activity of antituberculosis agents against anaerobic bacteria. Chest 1979, 75, 569-570. (Pubitemid 9178582)
15. Cosma, C.L.; Sherman, D.R.; Ramakrishnan, L. The secret lives of the pathogenic mycobacteria. Annu. Rev. Microbiol. 2003, 57, 641-676.
16. 6. Cardona, P.J. A Dynamic Reinfection Hypothesis of Latent Tuberculosis Infection. Infection 2009, Epub ahead of print.
17. Ehlers, S. Lazy, dynamic or minimally recrudescent- On the elusive nature and location of the mycobacterium responsible for latent tuberculosis. Infection 2009, 37, 85-95.
18. Mitchison, D.A. Basic mechanisms of chemotherapy. Chest 1979, 76, 771-781.
19. Dickinson, J.M.; Mitchison, D.A. Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis. Am. Rev. Respir. Dis. 1981, 123, 367-371.
20. Lewis, K. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 2007, 5, 48-56.
21. Archuleta, R.J.; Yvonne Hoppes, P.; Primm, T.P. Mycobacterium avium enters a state of metabolic dormancy in response to starvation. Tuberculosis (Edinb) 2005, 85, 147-158.
22. Hu, Y.M.; Butcher, P.D.; Sole, K.; Mitchison, D.A.; Coates, A.R. Protein synthesis is shutdown in dormant Mycobacterium tuberculosis and is reversed by oxygen or heat shock. FEMS Microbiol. Lett. 1998, 158, 139-145.
23. Pieters, J.; Gatfield, J. Hijacking the host: Survival of pathogenic mycobacteria inside macrophages. Trends Microbiol. 2002, 10, 142-146.
24. Olakanmi, O.; Schlesinger, L.S.; Ahmed, A.; Britigan, B.E. The nature of extracellular iron influences iron acquisition by mycobacterium tuberculosis residing within human macrophages. Infect. Immun. 2004, 72, 2022-2028.
25. Wagner, D.; Maser, J.; Lai, B.; Cai, Z.; Barry, C.E., 3rd; Honer Zu Bentrup, K.; Russell, D.G.; Bermudez, L.E. Elemental analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis-containing phagosomes indicates pathogen-induced microenvironments within the host cell's endosomal system. J. Immunol. 2005, 174, 1491-1500.
26. Cole, S.T.; Brosch, R.; Parkhill, J.; Garnier, T.; Churcher, C.; Harris, D.; Gordon, S.V.; Eiglmeier, K.; Gas, S.; Barry, C.E., 3rd; Tekaia, F.; Badcock, K.; Basham, D.; Brown, D.; Chillingworth, T.; Connor, R.; Davies, R.; Devlin, K.; Feltwell, T.; Gentles, S.; Hamlin, N.; Holroyd, S.; Hornsby, T.; Jagels, K.; Krogh, A.; McLean, J.; Moule, S.; Murphy, L.; Oliver, K.; Osborne, J.; Quail, M. A.; Rajandream, M.A.; Rogers, J.; Rutter, S.; Seeger, K.; Skelton, J.; Squares, R.; Squares, S.; Sulston, J.E.; Taylor, K.; Whitehead, S.; Barrell, B.G. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998, 393, 537-544.
27. Betts, J.C.; Lukey, P.T.; Robb, L.C.; McAdam, R.A.; Duncan, K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 2002, 43, 717-731.
28. Fisher, M.A.; Plikaytis, B.B.; Shinnick, T.M. Microarray analysis of the Mycobacterium tuberculosis transcriptional response to the acidic conditions found in phagosomes. J. Bacteriol. 2002, 184, 4025-4032.
29. Kettman, J.R.; Frey, J.R.; Lefkovits, I. Proteome, transcriptome and genome: Top down or bottom up analysis- Biomol. Eng. 2001, 18, 207-212.
30. Bantscheff, M.; Schirle, M.; Sweetman, G.; Rick, J.; Kuster, B. Quantitative mass spectrometry in proteomics: A critical review. Anal. Bioanal. Chem. 2007, 389, 1017-1031.
31. Aebersold, R.; Mann, M. Mass spectrometry-based proteomics. Nature 2003, 422, 198-207.
32. Patterson, S.D.; Aebersold, R.H. Proteomics: The first decade and beyond. Nat. Genet. 2003, 33 (Suppl.), 311-323.
33. de Godoy, L.M.; Olsen, J.V.; de Souza, G.A.; Li, G.; Mortensen, P.; Mann, M. Status of complete proteome analysis by mass spectrometry: SILAC labeled yeast as a model system. Genome Biol. 2006, 7, R50.
34. Hack, C.J. Integrated transcriptome and proteome data: The challenges ahead. Brief. Funct. Genomic. Proteomic. 2004, 3, 212-219.
35. Garin, J.; Diez, R.; Kieffer, S.; Dermine, J.F.; Duclos, S.; Gagnon, E.; Sadoul, R.; Rondeau, C.; Desjardins, M. The phagosome proteome: Insight into phagosome functions. J. Cell Biol. 2001, 152, 165-180.
36. Emans, N.; Nzala, N.N.; Desjardins, M. Protein phosphorylation during phagosome maturation. FEBS Lett. 1996, 398, 37-42.
37. Buchmeier, N.A.; Heffron, F. Inhibition of macrophage phagosome-lysosome fusion by Salmonella typhimurium. Infect. Immun. 1991, 59, 2232-2238.
38. Eriksson, S.; Lucchini, S.; Thompson, A.; Rhen, M.; Hinton, J.C. Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica. Mol. Microbiol. 2003, 47, 103-118.
39. Olakanmi, O.; Stokes, J.B.; Britigan, B.E. Acquisition of iron bound to low molecular weight chelates by human monocyte-derived macrophages. J. Immunol. 1994, 153, 2691-2703.
40. Anes, E.; Peyron, P.; Staali, L.; Jordao, L.; Gutierrez, M.G.; Kress, H.; Hagedorn, M.; Maridonneau-Parini, I.; Skinner, M.A.; Wildeman, A.G.; Kalamidas, S.A.; Kuehnel, M.; Griffiths, G. Dynamic life and death interactions between Mycobacterium smegmatis and J774 macrophages. Cell Microbiol. 2006, 8, 939-960.
41. Mattow, J.; Siejak, F.; Hagens, K.; Becher, D.; Albrecht, D.; Krah, A.; Schmidt, F.; Jungblut, P. R.; Kaufmann, S.H.; Schaible, U.E. Proteins unique to intraphagosomally grown Mycobacterium tuberculosis. Proteomics 2006, 6, 2485-2494.
42. Koul, A.; Herget, T.; Klebl, B.; Ullrich, A. Interplay between mycobacteria and host signalling pathways. Nat. Rev. Microbiol. 2004, 2, 189-202.
43. Sritharan, M. Iron as a candidate in virulence and pathogenesis in mycobacteria and other microorganisms. World J. Microb. Biotechnol. 2000, 16, 769-780.
44. Ong, S.T.; Ho, J.Z.; Ho, B.; Ding, J.L. Iron-withholding strategy in innate immunity. Immunobiology 2006, 211, 295-314.
45. Banerjee, S.; Nandyala, A.K.; Raviprasad, P.; Ahmed, N.; Hasnain, S.E. Iron-dependent RNA-binding activity of Mycobacterium tuberculosis aconitase. J. Bacteriol. 2007, 189, 4046-4052.
46. Johnsson, K.; Froland, W.A.; Schultz, P.G. Overexpression, purification, and characterization of the catalase-peroxidase KatG from Mycobacterium tuberculosis. J. Biol. Chem. 1997, 272, 2834-2840.
47. Lundrigan, M.D.; Arceneaux, J.E.; Zhu, W.; Byers, B.R. Enhanced hydrogen peroxide sensitivity and altered stress protein expression in iron-starved Mycobacterium smegmatis. Biometals 1997, 10, 215-225.
48. Harrison, A.J.; Yu, M.; Gardenborg, T.; Middleditch, M.; Ramsay, R.J.; Baker, E.N.; Lott, J.S. The structure of MbtI from Mycobacterium tuberculosis, the first enzyme in the biosynthesis of the siderophore mycobactin, reveals it to be a salicylate synthase. J. Bacteriol. 2006, 188, 6081-6091.
49. Rodriguez, G.M. Control of iron metabolism in Mycobacterium tuberculosis. Trends Microbiol. 2006, 14, 320-327.
50. Ferreras, J.A.; Ryu, J.S.; Di Lello, F.; Tan, D.S.; Quadri, L.E. Small-molecule inhibition of siderophore biosynthesis in Mycobacterium tuberculosis and Yersinia pestis. Nat. Chem. Biol. 2005, 1, 29-32.
51. Holmes, M.A.; Paulsene, W.; Jide, X.; Ratledge, C.; Strong, R.K. Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure 2005, 13, 29-41.
52. Imlay, J.A.; Chin, S.M.; Linn, S. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 1988, 240, 640-642.
53. Sritharan, M.; Yeruva, V.C.; Sivasailappan, S.C.; Duggirala, S. Iron enhances the susceptibility of pathogenic mycobacteria to isoniazid, an antitubercular drug. World J. Microbiol. Biotechnol. 2006, 22, 1357-1364.
54. Somoskovi, A.; Wade, M.M.; Sun, Z.; Zhang, Y. Iron enhances the antituberculous activity of pyrazinamide. J. Antimicrob. Chemother. 2004, 53, 192-196.
55. Rao, P.K.; Roxas, B.A.; Li, Q. Determination of global protein turnover in stressed mycobacterium cells using hybrid-linear ion trap-fourier transform mass spectrometry. Anal. Chem. 2008, 80, 396-406.
56. Rao, P.K.; Rodriguez, G.M.; Smith, I.; Li, Q. Protein dynamics in iron-starved Mycobacterium tuberculosis revealed by turnover and abundance measurement using hybrid-linear ion trap-Fourier transform mass spectrometry. Anal. Chem. 2008, 80, 6860-6869.
57. Rho, B.S.; Hung, L.W.; Holton, J.M.; Vigil, D.; Kim, S.I.; Park, M.S.; Terwilliger, T.C.; Pedelacq, J.D. Functional and structural characterization of a thiol peroxidase from Mycobacterium tuberculosis. J. Mol. Biol. 2006, 361, 850-863.
58. Master, S.S.; Springer, B.; Sander, P.; Boettger, E.C.; Deretic, V.; Timmins, G.S. Oxidative stress response genes in Mycobacterium tuberculosis: role of ahpC in resistance to peroxynitrite and stage-specific survival in macrophages. Microbiology 2002, 148, 3139-3144.
59. Guimaraes, B.G.; Souchon, H.; Honore, N.; Saint-Joanis, B.; Brosch, R.; Shepard, W.; Cole, S.T.; Alzari, P.M. Structure and mechanism of the alkyl hydroperoxidase AhpC, a key element of the Mycobacterium tuberculosis defense system against oxidative stress. J. Biol. Chem. 2005, 280, 25735-25742.
60. Sherman, D.R.; Mdluli, K.; Hickey, M.J.; Arain, T.M.; Morris, S.L.; Barry, C.E., 3rd; Stover, C.K., Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 1996, 272, 1641-1643.
61. Hu, Y.; Coates, A.R. Acute and persistent Mycobacterium tuberculosis infections depend on the thiol peroxidase TpX. PLoS One 2009, 4, e5150.
62. Rouse, D.A.; Li, Z.; Bai, G.H.; Morris, S.L. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 1995, 39, 2472-2477.
63. Rodriguez, G.M.; Smith, I. Mechanisms of iron regulation in mycobacteria: Role in physiology and virulence. Mol. Microbiol. 2003, 47, 1485-1494.
64. Escolar, L.; Perez-Martin, J.; de Lorenzo, V. Opening the iron box: transcriptional metalloregulation by the Fur protein. J. Bacteriol. 1999, 181, 6223-6229.
65. Cotter, P.D.; Hill, C. Surviving the acid test: Responses of gram-positive bacteria to low pH. Microbiol. Mol. Biol. Rev. 2003, 67, 429-453.
66. Kuehnel, M.P.; Goethe, R.; Habermann, A.; Mueller, E.; Rohde, M.; Griffiths, G.; Valentin-Weigand, P. Characterization of the intracellular survival of Mycobacterium avium ssp. paratuberculosis: Phagosomal pH and fusogenicity in J774 macrophages compared with other mycobacteria. Cell Microbiol. 2001, 3, 551-566.
67. Rohde, K.H.; Abramovitch, R.B.; Russell, D.G. Mycobacterium tuberculosis invasion of macrophages: linking bacterial gene expression to environmental cues. Cell Host Microbe 2007, 2, 352-364.
68. Sturgill-Koszycki, S.; Schlesinger, P.H.; Chakraborty, P.; Haddix, P.L.; Collins, H.L.; Fok, A.K.; Allen, R.D.; Gluck, S.L.; Heuser, J.; Russell, D.G. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 1994, 263, 678-681.
69. Roxas, B.A. System based proteomics analysis of the adaptation of Mycobacterium smegmatis to acid stress. Master's Thesis, Illinois, University of Illinois at Chicago, Chicago, USA, 2009.
70. Voskuil, M.I.; Schnappinger, D.; Visconti, K.C.; Harrell, M.I.; Dolganov, G.M.; Sherman, D.R.; Schoolnik, G.K. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 2003, 198, 705-713.
71. Rustad, T.R.; Harrell, M.I.; Liao, R.; Sherman, D.R. The enduring hypoxic response of Mycobacterium tuberculosis. PLoS One 2008, 3, e1502.
72. Murphy, D.J.; Brown, J.R. Novel drug target strategies against Mycobacterium tuberculosis. Curr. Opin. Microbiol. 2008, 11, 422-427.
73. Wayne, L.G.; Hayes, L.G., An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 1996, 64, 2062-2069.
74. Wayne, L.G.; Sramek, H.A. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 1994, 38, 2054-2058.
75. Cho, S.H.; Goodlett, D.; Franzblau, S. ICAT-based comparative proteomic analysis of non-replicating persistent Mycobacterium tuberculosis. Tuberculosis (Edinb) 2006, 86, 445-460.
76. Starck, J.; Kallenius, G.; Marklund, B.I.; Andersson, D.I.; Akerlund, T. Comparative proteome analysis of Mycobacterium tuberculosis grown under aerobic and anaerobic conditions. Microbiology 2004, 150, 3821-3829.
77. Henderson, B.; Allan, E.; Coates, A.R. Stress wars: the direct role of host and bacterial molecular chaperones in bacterial infection. Infect. Immun. 2006, 74, 3693-3706.
78. Ellner, J.J. Review: the immune response in human tuberculosis-- implications for tuberculosis control. J. Infect. Dis. 1997, 176, 1351-1359.
79. Li, Q. Advances in protein turnover analysis at the global level and biological insights. Mass Spectrom. Rev. 2009, in press.
80. Goldberg, A.L.; Dice, J.F. Intracellular protein degradation in mammalian and bacterial cells. Annu. Rev. Biochem. 1974, 43, 835-869.
81. Mandelstam, J. Turnover of protein in growing and non-growing populations of Escherichia coli. Biochem. J. 1958, 69, 110-119.
82. Larrabee, K.L.; Phillips, J.O.; Williams, G.J.; Larrabee, A.R. The relative rates of protein synthesis and degradation in a growing culture of Escherichia coli. J. Biol. Chem. 1980, 255, 4125-4130.
83. Hamdan, M.; Righetti, P.G. Modern strategies for protein quantification in proteome analysis: advantages and limitations. Mass Spectrom. Rev. 2002, 21, 287-302.
84. Cargile, B.J.; Bundy, J.L.; Grunden, A.M.; Stephenson, J.L., Jr. Synthesis/degradation ratio mass spectrometry for measuring relative dynamic protein turnover. Anal. Chem. 2004, 76, 86-97.
85. Pratt, J.M.; Petty, J.; Riba-Garcia, I.; Robertson, D.H.; Gaskell, S.J.; Oliver, S.G.; Beynon, R.J. Dynamics of protein turnover, a missing dimension in proteomics. Mol. Cell Proteomics 2002, 1, 579-591.
86. Malen, H.; Berven, F.S.; Fladmark, K.E.; Wiker, H.G. Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics 2007, 7, 1702-1718.
87. Rosenkrands, I.; Slayden, R.A.; Crawford, J.; Aagaard, C.; Barry, C.E., 3rd; Andersen, P. Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins. J. Bacteriol. 2002, 184, 3485-3491.
88. Spudich, J.A.; Kornberg, A. Biochemical studies of bacterial sporulation and germaination. VII. Protein turnover during sporulation of Bacillus subtilis. J. Biol. Chem. 1968, 243, 4600-4605.
89. Bernlohr, R.W. Changes in amino acid permeation during sporulation. J. Bacteriol. 1967, 93, 1031-1044.
90. Bernlohr, R.W. 18 Oxygen probes of protein turnover, amino acid transport, and protein synthesisin Bacillus licheniformis. J. Biol. Chem. 1972, 247, 4893-4899.